MicroRNA 2276 (MIR2276)

MicroRNA 2276 (MIR2276) is a human microRNA gene that encodes a short, 20–24 nucleotide non-coding RNA involved in the post-transcriptional regulation of gene expression. Like other microRNAs, it likely functions through base-pairing with complementary sequences in target mRNAs, leading to mRNA degradation or inhibition of translation. MIR2276 is annotated in major gene and RNA databases (miRBase, GeneCards, NCBI Gene), but there is limited or no disease-specific functional characterization available in major research publications. Its biological role is presumed to be similar to those of other microRNAs, including regulation of cellular processes such as cell cycle progression, differentiation, and apoptosis. Key findings and limitations: MIR2276 is a genuine microRNA gene in humans and is not misspelled or misannotated. It is not an established drug target, nor are there validated interacting drugs or biomarker applications specific to MIR2276 currently reported. There is no known disease association or therapeutic utility established for MIR2276 as of the latest available literature. Its inclusion in molecular and biomedical databases reflects recognized classification as a regulatory non-coding RNA (microRNA) and not as a protein or receptor. If more functional or disease-specific roles for MIR2276 emerge in future research, structured details could be updated accordingly.

Other names

hsa-mir-2276MIR2276microRNA 2276

As a microRNA, MIR2276 acts via sequence-specific binding to target mRNA, resulting in translational repression or degradation.